Please, complete the form to register for a session
Visualize The RNA World with RNAscope® Technology
September 11–14, 2017
Dates and locations
|Sep 11||Mon||12:30 pm
|Room 3120, Simches Research Building, Massachusetts General Hospital|
|Sep 12||Tue||10:00 am||Center for Life Sciences Bldg, 17th Floor, 3 Blackfan street, Brigham and Women's Hospital|
|Sep 12||Tue||1:00 pm||Room Cannon, Building C, 1st floor, Harvard Medical School|
|Sep 13||Wed||10:00 am||Translational Research Lab Building, University of Pennsylvania (closed session)*|
|Sep 13||Wed||2:00 pm||Room 123-C, Abramson Pediatric Research Center, Children's Hospital of Philadelphia|
|Sep 14||Thu||10:00 am||Room MSII (3813-17) University of Michigan, Ann Arbor|
Duration: 1h to 2h
Speakers and Presentations
Combined IHC and RNA ISH to elucidate tumor molecular heterogeneity
Nallasivam Palanisamy, Ph.D, Associate Scientist/Professor at Henry Ford Health System, Associate Professor (Adjunct) at
Current state-of-the-art tissue-based RNA analysis with
Courtney Anderson, Ph.D, Group Leader Applications,
RNAscope® is a proprietary RNA in situ hybridization (ISH) assay based on ACD patented signal amplification and background suppression technology which advances RNA biomarker analysis in tissues and cells. Unique to this technology, RNAscope® assay delivers quantitative, sensitive and specific molecular detection of RNA targets on a cell-by-cell basis with morphological context. The recent development of the BaseScope™ assay extends the use of this technology to detection of highly homologous targets, exon junctions, and circular RNAs expression in the tissue context.
With over 900 publications, RNAscope® Technology has proven to be an essential tool in cancer, immuno-oncology, neuroscience, gene therapy, stem cell, inflammation and infectious disease research and is commonly used to complement RNA-Seq, qPCR and IHC data.
During these sessions, Dr. Nalla Palanisamy will present his work on prostate cancer and discuss how RNA ISH has been successfully applied to his research. Courtney Anderson will demonstrate how this technology provides unique biological information and has been used in a multitude of research areas - cancer, neuroscience, gene therapy and more.
Please forward this invitation to your colleagues and other scientists in your organization who are using molecular methods for gene expression analysis and are interested in new RNA technologies.
* closed session: due to the university policy, this session will only be accessible to researchers from the University of Pennsylvania.